| Organism name | Pyrenacantha klaineana | 
|---|---|
| Genus | Pyrenacantha | 
| Family | Icacinaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Pyrenacantha | 
|---|---|
| Linked NCBI taxonomy ID | 85254 | 
| Linked level | genus | 
| Family in NCBI taxonomy | Icacinaceae | 
|---|---|
| ID | 4321 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | asterids | 
|---|---|
| ID | 71274 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00002145   | Camptothecin | CHEMBL65 CHEMBL276820 CHEMBL71836 | D002166 | 140 / 99 / 97 | 79 / 11 | No. 3696 | No. 7 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002145 | 1 / 0 | 
| P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00002145 | 0 / 0 | 
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002145 | 7 / 37 | 
| Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00002145 | 0 / 0 | 
| Q16637 | Survival motor neuron protein | Unclassified protein | C00002145 | 4 / 1 | 
| Q99700 | Ataxin-2 | Unclassified protein | C00002145 | 1 / 1 | 
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00002145 | 2 / 0 | 
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002145 | 0 / 0 | 
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002145 | 0 / 3 | 
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002145 | 2 / 2 | 
| P08246 | Neutrophil elastase | S1A | C00002145 | 2 / 1 | 
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00002145 | 0 / 0 | 
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002145 | 0 / 0 | 
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002145 | 0 / 0 | 
| P04062 | Glucosylceramidase | Enzyme | C00002145 | 6 / 4 | 
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002145 | 1 / 1 | 
| P29466 | Caspase-1 | C14 | C00002145 | 0 / 0 | 
| P17252 | Protein kinase C alpha type | Alpha | C00002145 | 0 / 0 | 
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00002145 | 0 / 0 | 
| P14780 | Matrix metalloproteinase-9 | M10A | C00002145 | 2 / 2 | 
| O14757 | Serine/threonine-protein kinase Chk1 | Chk1 | C00002145 | 0 / 0 | 
| P02545 | Prelamin-A/C | Unclassified protein | C00002145 | 11 / 10 | 
| Q9NZJ5 | Eukaryotic translation initiation factor 2-alpha kinase 3 | Pek | C00002145 | 1 / 2 | 
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00002145 | 3 / 2 | 
| P00918 | Carbonic anhydrase 2 | Lyase | C00002145 | 1 / 2 | 
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002145 | 0 / 1 | 
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002145 | 1 / 1 | 
| P25021 | Histamine H2 receptor | Histamine receptor | C00002145 | 0 / 0 | 
| P35367 | Histamine H1 receptor | Histamine receptor | C00002145 | 0 / 0 | 
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002145 | 1 / 0 | 
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002145 | 0 / 0 | 
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002145 | 0 / 0 | 
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002145 | 0 / 0 | 
| P02768 | Serum albumin | Secreted protein | C00002145 | 0 / 0 | 
| P08183 | Multidrug resistance protein 1 | drug | C00002145 | 1 / 0 | 
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002145 | 0 / 0 | 
| P06241 | Tyrosine-protein kinase Fyn | Src | C00002145 | 0 / 0 | 
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002145 | 0 / 0 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002145 | 0 / 1 | 
| P54132 | Bloom syndrome protein | Enzyme | C00002145 | 1 / 2 | 
| Q9HBX9 | Relaxin receptor 1 | Relaxin receptor | C00002145 | 0 / 0 | 
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00002145 | 1 / 0 | 
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002145 | 1 / 8 | 
| P11387 | DNA topoisomerase 1 | Isomerase | C00002145 | 0 / 0 | 
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00002145 | 0 / 0 | 
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00002145 | 2 / 0 | 
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002145 | 0 / 0 | 
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002145 | 0 / 0 | 
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00002145 | 0 / 0 | 
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002145 | 0 / 0 | 
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00002145 | 0 / 0 | 
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002145 | 0 / 0 | 
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002145 | 1 / 1 | 
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002145 | 0 / 0 | 
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002145 | 1 / 0 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00002145 | 0 / 0 | 
| P68871 | Hemoglobin subunit beta | Secreted protein | C00002145 | 4 / 4 | 
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002145 | 0 / 0 | 
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00002145 | 0 / 0 | 
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002145 | 0 / 0 | 
| P42858 | Huntingtin | Unclassified protein | C00002145 | 1 / 1 | 
| O75496 | Geminin | Unclassified protein | C00002145 | 0 / 0 | 
| P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002145 | 0 / 0 | 
| P09651 | Heterogeneous nuclear ribonucleoprotein A1 | Unclassified protein | C00002145 | 0 / 0 | 
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002145 | 0 / 0 | 
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002145 | 0 / 0 | 
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00002145 | 0 / 0 | 
| P30988 | Calcitonin receptor | Calcitonin receptor | C00002145 | 0 / 0 | 
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00002145 | 1 / 0 | 
| P41143 | Delta-type opioid receptor | Opioid receptor | C00002145 | 0 / 0 | 
| Q92731 | Estrogen receptor beta | NR3A2 | C00002145 | 0 / 1 | 
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002145 | 0 / 0 | 
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00002145 | 0 / 0 | 
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002145 | 0 / 0 | 
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002145 | 1 / 0 | 
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002145 | 0 / 0 | 
| P08311 | Cathepsin G | S1A | C00002145 | 0 / 0 | 
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002145 | 1 / 0 | 
| P03956 | Interstitial collagenase | M10A | C00002145 | 0 / 1 | 
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002145 | 0 / 0 | 
| P42226 | Signal transducer and activator of transcription 6 | Unclassified protein | C00002145 | 0 / 0 | 
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002145 | 0 / 0 | 
| P04150 | Glucocorticoid receptor | NR3C1 | C00002145 | 0 / 1 | 
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002145 | 2 / 0 | 
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002145 | 0 / 0 | 
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002145 | 0 / 0 | 
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002145 | 2 / 0 | 
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002145 | 5 / 9 | 
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002145 | 1 / 0 | 
| P21452 | Substance-K receptor | Neurokinin receptor | C00002145 | 0 / 0 | 
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002145 | 0 / 0 | 
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002145 | 3 / 0 | 
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002145 | 0 / 0 | 
| P06280 | Alpha-galactosidase A | Enzyme | C00002145 | 1 / 1 | 
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002145 | 1 / 0 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00002145 | 0 / 0 | 
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002145 | 2 / 1 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002145 | 0 / 0 | 
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002145 | 3 / 3 | 
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002145 | 2 / 2 | 
| Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00002145 | 5 / 2 | 
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002145 | 0 / 0 | 
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002145 | 0 / 0 | 
| P03372 | Estrogen receptor | NR3A1 | C00002145 | 1 / 1 | 
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002145 | 1 / 0 | 
| P22303 | Acetylcholinesterase | Hydrolase | C00002145 | 1 / 0 | 
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002145 | 0 / 0 | 
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002145 | 0 / 0 | 
| P35372 | Mu-type opioid receptor | Opioid receptor | C00002145 | 0 / 0 | 
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002145 | 0 / 0 | 
| P25103 | Substance-P receptor | Neurokinin receptor | C00002145 | 0 / 0 | 
| P25105 | Platelet-activating factor receptor | PAF receptor | C00002145 | 0 / 0 | 
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002145 | 0 / 0 | 
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00002145 | 0 / 0 | 
| Q02880 | DNA topoisomerase 2-beta | Isomerase | C00002145 | 0 / 0 | 
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002145 | 0 / 0 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002145 | 1 / 1 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002145 | 0 / 1 | 
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002145 | 0 / 0 | 
| Q9UNA4 | DNA polymerase iota | Enzyme | C00002145 | 0 / 0 | 
| Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00002145 | 0 / 0 | 
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002145 | 0 / 0 | 
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002145 | 1 / 1 | 
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002145 | 0 / 0 | 
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00002145 | 0 / 0 | 
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002145 | 0 / 0 | 
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002145 | 1 / 1 | 
| P06239 | Tyrosine-protein kinase Lck | Src | C00002145 | 0 / 1 | 
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002145 | 0 / 0 | 
| O14746 | Telomerase reverse transcriptase | Enzyme | C00002145 | 5 / 5 | 
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002145 | 0 / 0 | 
| P40225 | Thrombopoietin | Unclassified protein | C00002145 | 1 / 1 | 
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002145 | 0 / 0 | 
| O00255 | Menin | Unclassified protein | C00002145 | 2 / 5 | 
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002145 | 1 / 2 | 
| P30874 | Somatostatin receptor type 2 | Somatostatin receptor | C00002145 | 0 / 0 | 
| P31391 | Somatostatin receptor type 4 | Somatostatin receptor | C00002145 | 0 / 0 | 
| P32745 | Somatostatin receptor type 3 | Somatostatin receptor | C00002145 | 0 / 0 | 
| P35346 | Somatostatin receptor type 5 | Somatostatin receptor | C00002145 | 0 / 0 | 
| P30872 | Somatostatin receptor type 1 | Somatostatin receptor | C00002145 | 0 / 0 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | C00002145 | 
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | C00002145 | 
| 375790 | AGRN | agrin | C00002145 | 
| 213 | ALB, PRO0883, PRO0903, PRO1341 | albumin | C00002145 | 
| 307 | ANXA4, ANX4, PIG28, ZAP36 | annexin A4 | C00002145 | 
| 581 | BAX, BCL2L4 | BCL2-associated X protein | C00002145 | 
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 | C00002145 | 
| 637 | BID, FP497 | BH3 interacting domain death agonist | C00002145 | 
| 332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 | C00002145 | 
| 672 | BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | breast cancer 1, early onset | C00002145 | 
| 675 | BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, GLM3, PNCA2 | breast cancer 2, early onset | C00002145 | 
| 51719 | CAB39, MO25 | calcium binding protein 39 | C00002145 | 
| 835 | CASP2, CASP-2, ICH1, NEDD-2, NEDD2, PPP1R57 | caspase 2, apoptosis-related cysteine peptidase (EC:3.4.22.55) | C00002145 | 
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | C00002145 | 
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | C00002145 | 
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | C00002145 | 
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 | C00002145 | 
| 6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 | C00002145 | 
| 6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 | C00002145 | 
| 891 | CCNB1, CCNB | cyclin B1 | C00002145 | 
| 1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) | C00002145 | 
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | C00002145 | 
| 634 | CEACAM1, BGP, BGP1, BGPI | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | C00002145 | 
| 10153 | CEBPZ, CBF, CBF2, HSP-CBF, NOC1 | CCAAT/enhancer binding protein (C/EBP), zeta | C00002145 | 
| 1508 | CTSB, APPS, CPSB | cathepsin B (EC:3.4.22.1) | C00002145 | 
| 54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic | C00002145 | 
| 1806 | DPYD, DHP, DHPDHASE, DPD | dihydropyrimidine dehydrogenase (EC:1.3.1.2) | C00002145 | 
| 9538 | EI24, EPG4, PIG8, TP53I8 | etoposide induced 2.4 | C00002145 | 
| 2033 | EP300, KAT3B, RSTS2, p300 | E1A binding protein p300 (EC:2.3.1.48) | C00002145 | 
| 9852 | EPM2AIP1 | EPM2A (laforin) interacting protein 1 | C00002145 | 
| 2067 | ERCC1, COFS4, RAD10, UV20 | excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) | C00002145 | 
| 2072 | ERCC4, ERCC11, FANCQ, RAD1, XPF | excision repair cross-complementing rodent repair deficiency, complementation group 4 | C00002145 | 
| 355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor | C00002145 | 
| 2232 | FDXR, ADXR | ferredoxin reductase (EC:1.18.1.6) | C00002145 | 
| 2395 | FXN, CyaY, FA, FARR, FRDA, X25 | frataxin (EC:1.16.3.1) | C00002145 | 
| 2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) | C00002145 | 
| 3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X | C00002145 | 
| 3183 | HNRNPC, C1, C2, HNRNP, HNRPC, SNRPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | C00002145 | 
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta | C00002145 | 
| 3570 | IL6R, CD126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80 | interleukin 6 receptor | C00002145 | 
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 | C00002145 | 
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene | C00002145 | 
| 3956 | LGALS1, GAL1, GBP | lectin, galactoside-binding, soluble, 1 | C00002145 | 
| 5606 | MAP2K3, MAPKK3, MEK3, MKK3, PRKMK3, SAPKK-2, SAPKK2 | mitogen-activated protein kinase kinase 3 (EC:2.7.12.2) | C00002145 | 
| 4217 | MAP3K5, ASK1, MAPKKK5, MEKK5 | mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25) | C00002145 | 
| 5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) | C00002145 | 
| 4137 | MAPT, DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, TAU | microtubule-associated protein tau | C00002145 | 
| 4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase | C00002145 | 
| 4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) | C00002145 | 
| 406929 | MIR138-1, MIRN138-1 | microRNA 138-1 | C00002145 | 
| 8440 | NCK2, GRB4, NCKbeta | NCK adaptor protein 2 | C00002145 | 
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | C00002145 | 
| 1263 | PLK3, CNK, FNK, PRK | polo-like kinase 3 (EC:2.7.11.21) | C00002145 | 
| 84152 | PPP1R1B, DARPP-32, DARPP32 | protein phosphatase 1, regulatory (inhibitor) subunit 1B (EC:3.1.3.16) | C00002145 | 
| 9055 | PRC1, ASE1 | protein regulator of cytokinesis 1 | C00002145 | 
| 5888 | RAD51, BRCC5, HRAD51, HsRad51, HsT16930, MRMV2, RAD51A, RECA | RAD51 recombinase | C00002145 | 
| 5889 | RAD51C, BROVCA3, FANCO, R51H3, RAD51L2 | RAD51 paralog C | C00002145 | 
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 | C00002145 | 
| 5933 | RBL1, CP107, PRB1, p107 | retinoblastoma-like 1 (p107) | C00002145 | 
| 5934 | RBL2, P130, Rb2 | retinoblastoma-like 2 (p130) | C00002145 | 
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A | C00002145 | 
| 6382 | SDC1, CD138, SDC, SYND1, syndecan | syndecan 1 | C00002145 | 
| 6606 | SMN1, BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3, SMA4, SMA@, SMN, SMNT, T-BCD541, TDRD16A | survival of motor neuron 1, telomeric | C00002145 | 
| 55512 | SMPD3, NSMASE2 | sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) (EC:3.1.4.12) | C00002145 | 
| 6667 | SP1 | Sp1 transcription factor | C00002145 | 
| 6670 | SP3, SPR2 | Sp3 transcription factor | C00002145 | 
| 6890 | TAP1, ABC17, ABCB2, APT1, D6S114E, PSF-1, PSF1, RING4, TAP1*0102N, TAP1N | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | C00002145 | 
| 30851 | TAX1BP3, TIP-1 | Tax1 (human T-cell leukemia virus type I) binding protein 3 | C00002145 | 
| 55775 | TDP1 | tyrosyl-DNA phosphodiesterase 1 (EC:3.1.4.-) | C00002145 | 
| 7057 | THBS1, THBS, THBS-1, TSP, TSP-1, TSP1 | thrombospondin 1 | C00002145 | 
| 8744 | TNFSF9, 4-1BB-L, CD137L | tumor necrosis factor (ligand) superfamily, member 9 | C00002145 | 
| 7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) | C00002145 | 
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 | C00002145 | 
| 9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 | C00002145 | 
| 11257 | TP53TG1, LINC00096, NCRNA00096, P53TG1, P53TG1-D, TP53AP1 | TP53 target 1 (non-protein coding) | C00002145 | 
| 7298 | TYMS, HST422, TMS, TS | thymidylate synthetase (EC:2.1.1.45) | C00002145 | 
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A | C00002145 | 
| 331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis | C00002145 | 
| 7518 | XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | C00002145 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency | Q99714 | 
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism | P20309 | 
| #202300 | Adrenocortical carcinoma, hereditary; adcc | P04637 | 
| #103780 | Alcohol dependence | P08172 P14416 P31645 | 
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 | Q99720 | 
| #609135 | Aplastic anemia | O14746 | 
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 | P04637 | 
| #613985 | Beta-thalassemia | P68871 | 
| #603902 | Beta-thalassemia, dominant inclusion body type | P68871 | 
| #210900 | Bloom syndrome; blm | P54132 | 
| #602025 | Body mass index quantitative trait locus 9; bmiq9 | P41968 | 
| #300615 | Brunner syndrome | P21397 | 
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a | P02545 | 
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | P02545 | 
| #118300 | Charcot-marie-tooth disease and deafness | Q01453 | 
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 | P02545 | 
| #118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a | Q01453 | 
| #162800 | Cyclic neutropenia | P08246 | 
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 | P51681 | 
| #119900 | Digital clubbing, isolated congenital | P15428 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #613989 | Dyskeratosis congenita, autosomal dominant, 2; dkca2 | O14746 | 
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 | P02545 | 
| #226980 | Epiphyseal dysplasia, multiple, with early-onset diabetes mellitus | Q9NZJ5 | 
| #133239 | Esophageal cancer | P04637 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #301500 | Fabry disease | P06280 | 
| #613659 | Gastric cancer | P04626 | 
| #137215 | Gastric cancer, hereditary diffuse; hdgc | P04626 | 
| #608013 | Gaucher disease, perinatal lethal | P04062 | 
| #230800 | Gaucher disease, type i | P04062 | 
| #230900 | Gaucher disease, type ii | P04062 | 
| #231000 | Gaucher disease, type iii | P04062 | 
| #231005 | Gaucher disease, type iiic | P04062 | 
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd | P24557 | 
| #137800 | Glioma susceptibility 1; glm1 | P04626 | 
| #232300 | Glycogen storage disease ii | P10253 | 
| #139393 | Guillain-barre syndrome, familial; gbs | Q01453 | 
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay | Q03164 | 
| #610140 | Heart-hand syndrome, slovenian type | P02545 | 
| #140700 | Heinz body anemias | P68871 | 
| #609423 | Human immunodeficiency virus type 1, susceptibility to | P41597 P51681 | 
| #143100 | Huntington disease; hd | P42858 | 
| #176670 | Hutchinson-gilford progeria syndrome; hgps | P02545 | 
| #145000 | Hyperparathyroidism 1; hrpt1 | O00255 | 
| #603373 | Hyperthyroidism, familial gestational | P16473 | 
| #609152 | Hyperthyroidism, nonautoimmune | P16473 | 
| #145900 | Hypertrophic neuropathy of dejerine-sottas | Q01453 | 
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 | P15428 | 
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 | P16473 | 
| #612244 | Inflammatory bowel disease 13; ibd13 | P08183 | 
| #603932 | Intervertebral disc disease; idd | P14780 | 
| #151623 | Li-fraumeni syndrome 1; lfs1 | P04637 | 
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 | P02545 | 
| #613688 | Long qt syndrome 2; lqt2 | Q12809 | 
| #211980 | Lung cancer | P00533 P04626 P04637 | 
| #608516 | Major depressive disorder; mdd | P08172 | 
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada | P02545 | 
| #615134 | Melanoma, cutaneous malignant, susceptibility to, 9; cmm9 | O14746 | 
| #300705 | Mental retardation, x-linked 17; mrx17 | Q99714 | 
| %300852 | Mental retardation, x-linked 88; mrx88 | P50052 | 
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 | Q99714 | 
| #613073 | Metaphyseal anadysplasia 2; mandp2 | P14780 | 
| #131100 | Multiple endocrine neoplasia, type i; men1 | O00255 | 
| #126200 | Multiple sclerosis, susceptibility to; ms | P08575 | 
| #613205 | Muscular dystrophy, congenital, lmna-related | P02545 | 
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b | P02545 | 
| #159900 | Myoclonic dystonia | P14416 | 
| #160900 | Myotonic dystrophy 1; dm1 | Q9NR56 | 
| #162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp | Q01453 | 
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 | P08246 | 
| #601665 | Obesity | P32245 | 
| #164230 | Obsessive-compulsive disorder; ocd | P31645 | 
| #604715 | Orthostatic intolerance | P23975 | 
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 | P00918 | 
| #167000 | Ovarian cancer | P04626 | 
| #260500 | Papilloma of choroid plexus; cpp | P04637 | 
| #168600 | Parkinson disease, late-onset; pd | P04062 | 
| #613135 | Parkinsonism-dystonia, infantile; pkdys | Q01959 | 
| #614742 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1; pfbmft1 | O14746 | 
| #178500 | Pulmonary fibrosis, idiopathic; ipf | O14746 | 
| #607276 | Resting heart rate, variation in | P08588 | 
| #275210 | Restrictive dermopathy, lethal | P02545 | 
| #604906 | Schizophrenia 9; sczd9 | P49798 | 
| #181500 | Schizophrenia; sczd | P49798 | 
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive | P08575 | 
| #609620 | Short qt syndrome 1; sqt1 | Q12809 | 
| #603903 | Sickle cell anemia | P68871 | 
| #253300 | Spinal muscular atrophy, type i; sma1 | Q16637 | 
| #253550 | Spinal muscular atrophy, type ii; sma2 | Q16637 | 
| #253400 | Spinal muscular atrophy, type iii; sma3 | Q16637 | 
| #271150 | Spinal muscular atrophy, type iv; sma4 | Q16637 | 
| #183090 | Spinocerebellar ataxia 2; sca2 | Q99700 | 
| #275355 | Squamous cell carcinoma, head and neck; hnscc | P04637 | 
| #187950 | Thrombocythemia 1; thcyt1 | P40225 | 
| #190300 | Tremor, hereditary essential, 1; etm1 | P35462 | 
| #610379 | West nile virus, susceptibility to | P51681 | 
| #112100 | Yt blood group antigen | P22303 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00033 | Adrenal carcinoma | O00255
                            (related) P04637 (related) | 
| H00034 | Carcinoid | O00255
                            (related) | 
| H00045 | Malignant islet cell carcinoma | O00255
                            (related) | 
| H00246 | Primary hyperparathyroidism | O00255
                            (related) | 
| H01102 | Pituitary adenomas | O00255
                            (related) | 
| H00764 | Cri du chat syndrome | O14746
                            (related) | 
| H01132 | Aplastic anemia (AA) | O14746
                            (related) | 
| H01299 | Idiopathic pulmonary fibrosis | O14746
                            (related) | 
| H00022 | Bladder cancer | O14746
                            (marker) P00533 (related) P04626 (related) P04637 (related) P68871 (marker) | 
| H00024 | Prostate cancer | O14746
                            (marker) | 
| H00016 | Oral cancer | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00017 | Esophageal cancer | P00533
                            (related) P04637 (related) P04637 (marker) P35354 (related) | 
| H00018 | Gastric cancer | P00533
                            (related) P04626 (related) P04637 (related) | 
| H00028 | Choriocarcinoma | P00533
                            (related) P03956 (related) P04626 (related) P04637 (related) | 
| H00030 | Cervical cancer | P00533
                            (related) P04626 (related) | 
| H00042 | Glioma | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00055 | Laryngeal cancer | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) | P00918
                            (related) | 
| H00436 | Osteopetrosis | P00918
                            (related) | 
| H00264 | Charcot-Marie-Tooth disease (CMT) | P02545
                            (related) Q01453 (related) | 
| H00294 | Dilated cardiomyopathy (DCM) | P02545
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P02545
                            (related) | 
| H00563 | Emery-Dreifuss muscular dystrophy | P02545
                            (related) | 
| H00590 | Congenital muscular dystrophies (CMD/MDC) | P02545
                            (related) | 
| H00593 | Limb-girdle muscular dystrophy (LGMD) | P02545
                            (related) | 
| H00601 | Hutchinson-Gilford progeria syndrome | P02545
                            (related) | 
| H00663 | Restrictive dermopathy | P02545
                            (related) | 
| H00665 | Mandibuloacral dysplasia | P02545
                            (related) | 
| H01216 | Left ventricular noncompaction (LVNC) | P02545
                            (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) P04626 (related) P04637 (related) Q92731 (marker) | 
| H00066 | Lewy body dementia (LBD) | P04062
                            (related) | 
| H00126 | Gaucher disease | P04062
                            (related) | 
| H00426 | Defects in the degradation of ganglioside | P04062
                            (related) | 
| H00810 | Progressive myoclonic epilepsy (PME) | P04062
                            (related) | 
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) | P04150
                            (related) | 
| H00019 | Pancreatic cancer | P04626
                            (related) P04637 (related) P04637 (marker) | 
| H00027 | Ovarian cancer | P04626
                            (related) P04637 (related) | 
| H00031 | Breast cancer | P04626
                            (related) P04626 (marker) P04637 (related) | 
| H00046 | Cholangiocarcinoma | P04626
                            (related) P04637 (related) P35354 (related) | 
| H00004 | Chronic myeloid leukemia (CML) | P04637
                            (related) | 
| H00005 | Chronic lymphocytic leukemia (CLL) | P04637
                            (related) | 
| H00006 | Hairy-cell leukemia | P04637
                            (related) | 
| H00008 | Burkitt lymphoma | P04637
                            (related) | 
| H00009 | Adult T-cell leukemia | P04637
                            (related) | 
| H00010 | Multiple myeloma | P04637
                            (related) | 
| H00013 | Small cell lung cancer | P04637
                            (related) | 
| H00014 | Non-small cell lung cancer | P04637
                            (related) | 
| H00015 | Malignant pleural mesothelioma | P04637
                            (related) | 
| H00020 | Colorectal cancer | P04637
                            (related) P04637 (marker) P68871 (marker) | 
| H00025 | Penile cancer | P04637
                            (related) P04637 (marker) P14780 (related) P35354 (related) | 
| H00029 | Vulvar cancer | P04637
                            (related) | 
| H00032 | Thyroid cancer | P04637
                            (related) | 
| H00036 | Osteosarcoma | P04637
                            (related) P08684 (marker) | 
| H00038 | Malignant melanoma | P04637
                            (related) | 
| H00039 | Basal cell carcinoma | P04637
                            (related) | 
| H00040 | Squamous cell carcinoma | P04637
                            (related) | 
| H00041 | Kaposi's sarcoma | P04637
                            (related) | 
| H00044 | Cancer of the anal canal | P04637
                            (related) | 
| H00047 | Gallbladder cancer | P04637
                            (related) | 
| H00048 | Hepatocellular carcinoma | P04637
                            (related) | 
| H00881 | Li-Fraumeni syndrome | P04637
                            (related) | 
| H01007 | Choroid plexus papilloma | P04637
                            (related) | 
| H00021 | Renal cell carcinoma | P04637
                            (marker) | 
| H00093 | Combined immunodeficiencies (CIDs) | P06239
                            (related) | 
| H00125 | Fabry disease | P06280
                            (related) | 
| H00079 | Asthma | P07550
                            (related) | 
| H00100 | Neutropenic disorders | P08246
                            (related) | 
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) | P08575
                            (related) | 
| H00069 | Glycogen storage diseases (GSD) | P10253
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00479 | Metaphyseal dysplasias | P14780
                            (related) | 
| H00457 | Primary hypertrophic osteoarthropathy (PHO) | P15428
                            (related) | 
| H01246 | Isolated congenital nail clubbing (ICNC) | P15428
                            (related) | 
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) | P16473
                            (related) | 
| H01269 | Congenital hyperthyroidism | P16473
                            (related) | 
| H00548 | Brunner syndrome | P21397
                            (related) | 
| H01031 | Orthostatic intolerance (OI) | P23975
                            (related) | 
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) | P24557
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) | P40225
                            (marker) | 
| H00059 | Huntington's disease (HD) | P42858
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | P50052
                            (related) Q99714 (related) | 
| H00094 | DNA repair defects | P54132
                            (related) | 
| H00296 | Defects in RecQ helicases | P54132
                            (related) | 
| H00228 | Thalassemia | P68871
                            (related) | 
| H00229 | Sickle cell anemia (SCA) | P68871
                            (related) | 
| H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) | Q01453
                            (related) | 
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) | Q03164
                            (related) Q03164 (marker) | 
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) | Q03164
                            (related) | 
| H00720 | Long QT syndrome | Q12809
                            (related) | 
| H00725 | Short QT syndrome | Q12809
                            (related) | 
| H00455 | Spinal muscular atrophy (SMA) | Q16637
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q99700
                            (related) | 
| H00658 | Syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency | Q99714
                            (related) | 
| H00512 | Permanent neonatal diabetes mellitus (PNDM) | Q9NZJ5
                            (related) | 
| H00766 | Wolcott-Rallison syndrome | Q9NZJ5
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D003967 | Diarrhea | C00002145 | 
| D005621 | Friedreich Ataxia | C00002145 | 
| D005910 | Glioma | C00002145 | 
| D018316 | Gliosarcoma | C00002145 | 
| D006816 | Huntington Disease | C00002145 | 
| D007945 | Leukemia, Lymphoid | C00002145 | 
| D007968 | Leukoencephalopathy, Progressive Multifocal | C00002145 | 
| D009369 | Neoplasms | C00002145 | 
| D009374 | Neoplasms, Experimental | C00002145 | 
| D009503 | Neutropenia | C00002145 | 
| D024801 | Tauopathies | C00002145 |